Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Finance Watch: VC Investment Soars In Q1, Putting Biopharma On Track For A Record Year

Executive Summary

Pharma and biotech companies raised $4.6bn in the first quarter, exceeding the 2017 quarterly average by $1.4bn. But while the money invested soared, the number of companies funded sank. In public financings, MorphoSys commences US IPO and Mylan sells $1.5bn in notes.

Advertisement

Related Content

Enterprise Therapeutics Raises £29M To Advance Respiratory Assets
Israeli Startup Ayala Taking BMS Cancer Drug Into Phase II With $17m Financing
ITBMed Raises $67M To Induce Organ Transplant Tolerance
Sofinnova Targets Later Stage Firms With €275M Healthcare Crossover Fund
Deal Watch: Allogene Gets Pfizer's Off-The-Shelf CAR-T Program, $300m Series A Backing
AstraZeneca Keeps R&D Focus, Spins Out Phase II Neuromyelitis Optica MAb Into New Biotech
Pionyr Maps Tumor Microenvironment, Plans 'Surgical' Strikes
Pipeline Watch: Phase III Readouts For Talazoparib, Ampion, Avatrombopag
Finance Watch: Canaan Closes New VC Fund; CARB-X Backs More Antibiotics
Startups Stand Out As 13 Biotechs Raise More Than $409m

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC122884

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel